Savara (SVRA) Change in Taxes (2017 - 2018)

Savara (SVRA) reported Change in Taxes of $156000.0 for Q3 2018, up 31.09% year-over-year from $119000.0 in Q3 2017, and down 57.14% quarter-over-quarter from $364000.0 in Q2 2018.

Savara (SVRA) Change in Taxes (2017 - 2018) Analysis & Trends

Savara (SVRA) has 2 years of Change in Taxes data on file, last reported at $156000.0 in Q3 2018.

  • Change in Taxes for Q3 2018 came in at $156000.0, up 31.09% year-over-year; the trailing twelve-month figure through Sep 2018 was $1.1 million (changed N/A YoY), and the FY2017 annual result was $454000.0, up 215.52% from the prior year.
  • Change in Taxes slipped to $156000.0 in Q3 2018 per SVRA's latest filing, from $364000.0 in the prior quarter.
  • Over five years, Change in Taxes peaked at $873000.0 in Q1 2018 and troughed at -$331000.0 in Q4 2017.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Savara 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2018 156,000.00
Sep 30, 2018 156,000.00
Jun 30, 2018 364,000.00
Jun 30, 2018 364,000.00
Mar 31, 2018 873,000.00
Mar 31, 2018 873,000.00
Dec 31, 2017 -331,000.00
Dec 31, 2017 -331,000.00
Sep 30, 2017 119,000.00
Sep 30, 2017 119,000.00
Jun 30, 2017 501,000.00
Jun 30, 2017 501,000.00
Mar 31, 2017 165,000.00
Mar 31, 2017 165,000.00